Clinical Context Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated A study published in Frontiers in veterinary science in 2026 evaluated short-term effects of pimobendan in dogs with preclinical myxomatous mitral valve disease..

Key Findings Pimobendan has been shown to delay the onset of congestive heart failure and prolong survival in dogs affected by myxomatous mitral valve disease (MMVD). However, little information is available regarding its short-term echocardiographic effects in dogs with preclinical disease. The aim of this prospective multicenter observational study was to evaluate the effect of pimobendan on selected echocardiographic indices after 7 days of therapy in dogs with American College…